quetiapine fumarate
(kwe tie' ah peen)
Seroquel
Pregnancy Category C
Drug classes
Dibenzothiazepine
Antipsychotic
Therapeutic actions
Mechanism of action not fully understood: Blocks dopamine and serotonin receptors in the brain; also acts as a receptor antagonist at histamine and adrenergic receptor sites (which may contribute to the adverse effects of orthostatic hypotension and somnolence).
Indications
· Treatment of schizophrenia in patients > 18 yr
· Short-term treatment of acute manic episodes associated with bipolar I disorder, as monotherapy or in combination with lithium or divalproex
Contraindications and cautions
· Contraindicated with coma or severe CNS depression, allergy to quetiapine, lactation.
· Use cautiously with CV disease, hypotension, hepatic dysfunction, seizures, exposure to extreme heat, autonomic instability, tardive dyskinesia, dehydration, thyroid disease, pregnancy.
Available forms
Tablets—25, 100, 200, 300 mg
Dosages
ADULTS
· Schizophrenia: 25 mg PO bid. Increase in increments of 25–50 mg bid–tid on days 2 and 3; dosage range by day 4: 300–400 mg/day in two to three divided doses. Further increases can be made at 2-day intervals. Maximum dose, 800 mg/day.
· Manic episodes: 100 mg/day PO divided bid on day 1; increase to 400 mg/day PO in bid divided doses by day 4 using 100-mg/day increments. Range, 400–800 mg/day given in divided doses.
PEDIATRIC PATIENTS
Not recommended for patients < 18 yr old.
GERIATRIC OR DEBILITATED PATIENTS OR PATIENTS WITH HEPATIC IMPAIRMENT
Use lower doses starting with 25 mg/day and increase dosage more gradually than in other patients.
Pharmacokinetics
Route | Onset | Peak | Duration |
Oral | Slow | 1.5 hr | Unknown |
Metabolism: Hepatic; T1/2: 6 hr
Distribution: Crosses placenta; enters breast milk
Excretion: Feces, urine
Adverse effects
· Autonomic: Dry mouth, salivation, nasal congestion, nausea, vomiting, anorexia, fever, pallor, flushed facies, sweating, constipation
· CNS: Drowsiness, insomnia, vertigo, headache, weakness, tremor, tardive dyskinesias, neuroleptic malignant syndrome
· CV: Hypotension, orthostatic hypotension, syncope
· Hematologic: Increased ALT, total cholesterol and triglycerides
· Other: Risk of development of diabetes mellitus
Interactions
Drug-drug
· CNS effects potentiated by alcohol, CNS depressants
· Effects decreased with phenytoin, thioridazine, carbamazepine, phenobarbital, rifampin, glucocorticoids; monitor patient closely and adjust dosages appropriately when these drugs are added to or discontinued from regimen
· Increased effects of antihypertensives, lorazepam
· Decreased effects of levodopa, dopamine antagonists
· Potential for heatstroke and intolerance with drugs that affect temperature regulation (anticholinergics); use extreme caution and monitor patient closely
Nursing considerations
Assessment
· History: Coma or severe CNS depression; allergy to quetiapine, lactation, pregnancy, CV disease, hypotension, hepatic dysfunction, seizures, exposure to extreme heat, autonomic instability, tardive dyskinesia, dehydration, thyroid disease, suicidal tendencies
· Physical: Body weight, T; reflexes, orientation, IOP; P, BP, orthostatic BP; R, adventitious sounds; CBC, urinalysis, LFTs, renal and thyroid function tests
Interventions
· WARNING: Administer small quantity to any patient with suicidal ideation.
· Monitor elderly patients for dehydration and institute remedial measures promptly; sedation and decreased sensation of thirst related to CNS effects of drug can lead to severe dehydration.
· Monitor patient closely in any setting that would promote overheating.
· Regularly monitor patient for signs and symptoms of diabetes mellitus.
· Consult physician about dosage reduction and use of anticholinergic antiparkinsonians (controversial) if extrapyramidal effects occur.
Teaching points
· Take this drug exactly as prescribed.
· This drug should not be used during pregnancy; using barrier contraceptives is advised.
· Maintain fluid intake and use precautions against heat stroke in hot weather.
· You may experience these side effects: Dizziness, drowsiness, fainting (avoid driving or engaging in other dangerous activities); dry mouth, nausea, loss of appetite (frequent mouth care, frequent small meals, and increased fluid intake may help).
· Report sore throat, fever, unusual bleeding or bruising, rash, weakness, tremors, dark-colored urine, pale stools, yellowing of the skin or eyes, suicidal thoughts.
Adverse effects in Italic are most common; those in Bold are life-threatening.
0 comments:
Post a Comment